Navigation Links
First Embryos in UK Screened for Disease

Twins Freddie and Thomas Greenstreet were born two weeks ago to parents Catherine and Jim following a test, pre-implantation genetic haplotyping that screens for genetic// diseases.

The Greenstreets already have a daughter affected by cystic fibrosis (CF). Pre-implantation genetic haplotyping looks for a genetic 'fingerprint' of diseases such as CF, sickle cell disease, Huntington's disease, Duchenne muscular dystrophy and spinal muscular atrophy.

Unlike other tests it looks at the whole DNA of a cell from an embryo, rather than focusing on a specific mutation in one gene, making it quicker to spot diseases. In addition researchers also look at genetic clues for the disease in the mother and father. The presence of a particular number suggests the embryo is affected.

Both Catherine and her husband Jim, from Chiswick, carry the CF gene. The couple already have twins, Lizzie and William aged five. Lizzie has CF.

The Greenstreets' embryos were tested by doctors at Guy's and St Thomas' Hospital in London to identify those that were unaffected by the condition. This was followed by the implantation of healthy embryos.

Catherine said: "The whole family is very excited about the arrival of Freddie and Thomas.

"At one point we didn't think that we would be able to have any more children, so it is quite something to have two healthy, happy babies."

Professor Peter Braude, head of the department of women's health at King's College and clinical director of the pre-implantation genetic diagnosis (PGD) programme said: "PGD can make an enormous difference for some families who have repeatedly miscarried, lost children through serious genetic disease, or are living with a child suffering from a serious genetic disease.

"For these couples it allows them the best chance of avoiding a serious genetic disorder being diagnosed in pregnancy and, in some cases, the need for a termination of pregnancy."

However some such as Josephine Quintavalle, of Comment on Reproductive Ethics expressed their concerns about the message this test gave out.

She said: "It is not about the babies who have been born. It's about the babies who have not been allowed to be born. "It sends a particularly bad message to children with cystic fibrosis - that society would prefer that they had not been born."

Rosie Barnes, chief executive of the Cystic Fibrosis Trust said: 'Couples who know they are at risk from having a child with CF are often those who already have a child with CF, so know they are both carriers of the defective gene.'

"Understandably they think carefully before having another child.

"Knowing that CF is a life-threatening disease and that living with the daily burden of physiotherapy, oral, nebulised and intravenous antibiotics places a huge strain on all involved, many do not wish to bring another child with CF into the world.

"People should always be given the right to make their own informed choice, and this new development in PGD extends this choice, offering the option of having a healthy child without resorting to an abortion, to carriers of less common mutations of the CF gene."
NLA
'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV ... , The increasingly modern world of instantaneous consumption proves very convenient for businesses. ... such as oil and coal, which pollutes our air, water, and soil. It can ...
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Fisher House ... Vegas Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy ... at the VA Southern Nevada Healthcare System. This will be the first Fisher ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
(Date:2/11/2016)... 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced ... 31, 2015. The Company also filed its Quarterly Report on ... with the Securities and Exchange Commission today. ... --> --> Net sales ... million, or 95%, to $5.4 million from $2.8 million for ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology: